Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptide

Clinical Laboratory

Volumn 58, Issue 5-6, 2012, Pages 515-525

  Jorgensen B O ^a   Bertsch, Thomas ^b   Bröker, Hans Joachim ^c   Schäfer, Markus ^c   Chapelle, Jean Paul ^d   Gadisseur, Romy ^d   Cowie, Martin R ^e   Dikkeschei, Bert ^f   Gurr, Eberhard ^g   Hayen, Wiebke ^g   Hafner, Gerd ^h   Stiegler, Yuriko ^h   Schönherr, Hans Robert ⁱ   Strasser, Ruth H ^j   Weidtmann, Britta ^k   Folkerts, Henning ^k   Zugck, Christian ^l   Hofmann, Kerstin ^m   Zerback, Rainer ^m  

^a VIBORG HOSPITAL   (Denmark)

^b KLINIKUM NÜRNBERG   (Germany)

^c Diakonissenkrankenhaus Kassel   (Germany)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f Klinisch Chemisch Laboratorium   (Netherlands)

^g Klinikum Links der Weser   (Germany)

^h MVZLM Medizinisches Versorgungszentrum für Labormedizin und Mikrobiologie Ruhr GmbH   (Germany)

ⁱ Krankenhaus St Vinzenz   (Austria)

^j University Heart Center Dresden   (Germany)

^k UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^l UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^m ROCHE DIAGNOSTICS GMBH   (Germany)

more..

Author keywords

Analytical performance; Brain natriuretic peptide (BNP); Congestive heart failure; Multicentre evaluation; N terminal probnp (NT proBNP); Natriuretic peptides; Point of care testing

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BILIRUBIN; HEMOGLOBIN; TRIACYLGLYCEROL;

ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENVIRONMENTAL TEMPERATURE; FALSE NEGATIVE RESULT; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; JAUNDICE; MAJOR CLINICAL STUDY; MEASUREMENT ERROR; POINT OF CARE TESTING; PROTEIN DETERMINATION; REFERENCE VALUE; TRIACYLGLYCEROL BLOOD LEVEL;

ATRIAL NATRIURETIC FACTOR; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; POINT-OF-CARE SYSTEMS; PROTEIN PRECURSORS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TEMPERATURE;

EID: 84863638759     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Zugck C, Nelles M, Katus HA, et al. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood. Clin Chem Lab Med 2006;44:1269-77. (Pubitemid 44580811)
2. Bertsch T, Dikkeschei B, Gurr E, et al. Development and calibretion of a new point-of-care test for the determination of NT-proBNP in whole blood. Clin Lab 2007;53:423-31. (Pubitemid 47307637)
3. Bertsch T, Chapelle JP, Dempfle CE, Giannitsis E, Schwab M, Zerback R. Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers. Clin Lab 2010;56:37-49.
4. Müller-Bardorff M, Sylvén C, Rasmanis G, et al. Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med 2000;38:567-74. (Pubitemid 30639388)
5. Collinson PO, Jørgensen B, Sylvén C, et al. Recalibration of the point-of-care test for Cardiac T Quantitative with Elecsys Troponin T 3rd Generation. Clin Chim Acta 2001;307:197-203. (Pubitemid 32448925)
6. Giannitsis E, Baum H, Bertsch T, et al. Multicentre evaluation of a new point-of-care test for the determination of CK-MB in whole blood. Clin Chem Lab Med 2008;46:630-8. (Pubitemid 351749109)
7. Dempfle CE, Schraml M, Besenthal I, et al. Multicenter evaluation of a new point-of-care test for the quantitative determination of D-dimer. Clin Chim Acta 2001;307:211-8. (Pubitemid 32448927)
8. Alehagen U, Janzon M. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting. Eur J Heart Fail 2008;3:260-6.
9. Vizcaíno L, Lampón N, Marcos B, et al. Uselfulness of cobas h 232 (POCT) to measure cardiac markers in coronary emergencies. Point of Care 2008;7:211.
10. Zerback R, Fluder K, Schäfer M, et al. Point-of-care testing of NT-proBNP for differential diagnosis of patients presenting with dyspnea. Clin Res Cardiol 2009;98 (Suppl 2):P114.
11. Schäfer M, Bröker HJ, Luchner A, et al. Diagnostic equivalence of an N-terminal pro-brain natriuretic peptide point-of-care test to the laboratory method in patients with heart failure and in reference populations. Point of Care 2010; 9:91-7.
12. Yeo KTJ, Wu AHB, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clinica Chimica Acta 2003;338:107-15. (Pubitemid 37456696)
13. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004;6:365-8. (Pubitemid 38253059)
14. Sokoll LJ, Baum H, Collinson PO, et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 2004;42:965-72.
15. Fraser CG. Biological Variation: From Principles to Practice. AACC Press, Washington DC, 2001.
16. Wu AHB, Smith A, Wieczorek S, et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-31. (Pubitemid 37013426)
17. Clinical and Laboratory Standards Institute. Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition. CLSI document EP7-A2 [ISBN 1-56238-584-4]. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2005.
18. Möckel M, Müller R, Vollert JO, et al. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin Chem 2005;51:1624-31. (Pubitemid 41233097)